ALKS Stock Summary and Trading Ideas (Alkermes PLC - | NASDAQ:ALKS)

Alkermes PLC is a fully integrated biotechnology company that applies its proprietary technologies to research, develop, and commercialize pharmaceutical products designed for unmet medical needs in therapeutic areas. The company utilizes several to develop and commercialize products and, in so doing, access technological, financial, marketing, manufacturing, and other resources. Alkermes either purchases active drug products from third parties or receives them from its third-party licensees to formulate products using its technologies. It operates in U.S., which derives maximum revenue, Ireland and Rest of the world.

Alkermes PLC - trades on the NASDAQ stock market under the symbol ALKS.

As of December 13, 2024, ALKS stock price climbed to $30.51 with 1,377,955 million shares trading.

ALKS has a beta of 0.72, meaning it tends to be less sensitive to market movements. ALKS has a correlation of 0.07 to the broad based SPY ETF.

ALKS has a market cap of $4.94 billion. This is considered a Mid Cap stock.

Last quarter Alkermes PLC - reported $378 million in Revenue and $.72 earnings per share. This fell short of revenue expectation by $-2 million and missed earnings estimates by -$.02.

In the last 3 years, ALKS traded as high as $33.71 and as low as $21.75.

The top ETF exchange traded funds that ALKS belongs to (by Net Assets): IJR, IWM, VTI, CALF, VB.

ALKS has underperformed the market in the last year with a return of +11.3%, while SPY returned +29.9%. This shows that you would have done better investing in the overall market (through SPY) over the last year than in ALKS shares. However, ALKS has outperformed the market in the last 3 month and 2 week periods, returning +10.3% and +5.1%, while SPY returned +7.8% and +0.3%, respectively. This indicates ALKS has been having a stronger performance recently.

ALKS support price is $29.84 and resistance is $31.16 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that ALKS shares will trade within this expected range on the day.